Resource Centre
)
Workflow overview: whole-plasmid sequencing
- Plasmid
- Microbiology
- Biopharma
- Infectious disease
- Bacteria
- DNA
April 10 2025
)
Validation and quality control of a molecular cloning experiment using de novo assembly of Oxford Nanopore reads
- Plasmid
- London Calling
- EPI2ME
May 20 2025
)
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
- Plasmid
- Biopharma
- Direct analysis
- Amplicons
- mRNA
- AAV
April 16 2025
)
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
- Plasmid
- Biopharma
- AAV
- MinION
January 21 2025
)
)
Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario
- Plasmid
- Biopharma
- mRNA
- Flongle
September 6 2025
Navigating cell and gene therapy: the benefits of whole-genome profiling
- Plasmid
- Biopharma
- AAV
- Webinar
March 25 2025
)
London Calling 2024 technology update
- Plasmid
- Adaptive sampling
- Assembly
- Automation
- Basecalling
- Bioinformatics
May 24 2024
)
Improving bacterial metagenomic research through long-read sequencing
- Plasmid
- Bacteria
- Long-read
- Metagenomics
- Microbiology
- MinION
April 4 2024
)
iDTECT® Integration Site Analysis assay: a paradigm shift for the quality control of biologics in rare diseases
- Plasmid
- Microbiology
- London Calling
- Animal
- Variant calling
- Bioinformatics
May 24 2024
Giant extrachromosomal element “Inocle” potentially expands the adaptive capacity of the human oral microbiome
- Plasmid
- Microbiology
- Bacteria
- PromethION
October 1 2024
)
Getting started guide: biopharma
- Plasmid
- Biopharma
- Direct analysis
- Multiomics
- AAV
- Amplicons
October 15 2025
Enhancing cell and gene therapy success with multi-omic sequencing
- Plasmid
- AAV
- Biopharma
- Webinar
November 15 2024
)
)
Brochure: EPI2ME — data analysis for all levels of expertise
- Plasmid
- 16S
- AAV
- AMR
- Assembly
- Bacteria
May 1 2025
A single amino acid variant in the variable region I of AAV capsid confers liver de-targeting
- Plasmid
- Biopharma
- AAV
- Amplicons
March 5 2025
)
